1-3 of 3
Meredith Davis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

Hyunju Lee, F. Stephen Hodi, Anita Giobbie-Hurder, Patrick A. Ott, Elizabeth I. Buchbinder, Rizwan Haq, Sara Tolaney, Romualdo Barroso-Sousa, Kevin Zhang, Hilary Donahue, Meredith Davis, Maria E. Gargano, Kristina M. Kelley, Rona S. Carroll, Ursula B. Kaiser, Le Min
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (12): 1133–1140.
https://doi.org/10.1158/2326-6066.CIR-17-0208
Published: 30 November 2017
View article titled, Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy
Open the PDF for Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy in another window
Journal Articles

Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients

Marlene Garcia-Neuer, Melina E. Marmarelis, Sushrut R. Jangi, Jason J. Luke, Nageatte Ibrahim, Meredith Davis, Janice Weinberg, Hilary Donahue, Nancy Bailey, F. Stephen Hodi, Elizabeth L. Buchbinder, Patrick A. Ott
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (4): 286–291.
https://doi.org/10.1158/2326-6066.CIR-16-0302
Published: 02 April 2017
View article titled, Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients
Open the PDF for Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients in another window
Journal Articles

Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma

Jason J. Luke, Hilary Donahue, Mizuki Nishino, Anita Giobbie-Hurder, Meredith Davis, Nancy Bailey, Patrick A. Ott, F. Stephen Hodi
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (9): 986–991.
https://doi.org/10.1158/2326-6066.CIR-15-0066
Published: 03 September 2015
View article titled, Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma
Open the PDF for Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma in another window